10-K Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0000914475-22-000013`
Period End Date	20211231
Filing Date	20220211
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	nbix-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 63 Cash Flow Statement 89 Stockholders Equity 21

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$187.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$340.80M	USD	Point-in-time
Debt securities available-for-sale (amortized cost was $370.6 and $612.4 as of December 31, 2021 and 2020, respectively)	`MarketableSecuritiesCurrent`	$613.90M	USD	Point-in-time
Debt securities available-for-sale (amortized cost was $370.6 and $612.4 as of December 31, 2021 and 2020, respectively)	`MarketableSecuritiesCurrent`	$370.50M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$185.50M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$157.10M	USD	Point-in-time
Inventory	`InventoryNet`	$30.50M	USD	Point-in-time
Inventory	`InventoryNet`	$28.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$30.10M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$45.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.02B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$972.80M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$315.10M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$319.40M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Debt securities available-for-sale (amortized cost was $563.2 and $226.7 as of December 31, 2021 and 2020, respectively)	`MarketableSecuritiesNoncurrent`	$560.70M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Debt securities available-for-sale (amortized cost was $563.2 and $226.7 as of December 31, 2021 and 2020, respectively)	`MarketableSecuritiesNoncurrent`	$227.10M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$82.80M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$97.20M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$63.70M	USD	Point-in-time
Equity securities	`EquitySecuritiesFvNiRestricted`	$38.20M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$58.60M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$44.60M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	94.90M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.40M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$4.40M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	93.50M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	93.50M	shares	Point-in-time
Total assets	`Assets`	$2.07B	USD	Point-in-time
Total assets	`Assets`	$1.73B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	94.90M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$168.70M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$225.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$20.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$245.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$186.50M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$317.90M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$335.10M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$94.40M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$105.30M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$9.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$12.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$608.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$698.50M	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding as of December 31, 2021 and 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding as of December 31, 2021 and 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; 94.9 and 93.5 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, $0.001 par value; 220.0 shares authorized; 94.9 and 93.5 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.85B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.01B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.80M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-635.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-725.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$636.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.37B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.13B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$2.07B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.13B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$788.10M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.05B	USD	Annual
Cost of sales	`CostOfSales`	$14.30M	USD	Annual
Cost of sales	`CostOfSales`	$10.10M	USD	Annual
Cost of sales	`CostOfSales`	$7.40M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$328.10M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$275.00M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$200.00M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$164.50M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$154.30M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$105.30M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$433.30M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$583.30M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$354.10M	USD	Annual
Total operating expenses	`OperatingExpenses`	$882.90M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.03B	USD	Annual
Total operating expenses	`OperatingExpenses`	$715.80M	USD	Annual
Operating income	`OperatingIncomeLoss`	$72.30M	USD	Annual
Operating income	`OperatingIncomeLoss`	$102.50M	USD	Annual
Operating income	`OperatingIncomeLoss`	$163.00M	USD	Annual
Interest expense	`InterestExpense`	$32.00M	USD	Annual
Interest expense	`InterestExpense`	$25.80M	USD	Annual
Interest expense	`InterestExpense`	$32.80M	USD	Annual
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-17.70M	USD	Annual
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$20.90M	USD	Annual
Unrealized gain (loss) on equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-13.00M	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	$-18.40M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$19.20M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$3.80M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$12.60M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-1.10M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-25.80M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-56.30M	USD	Annual
Income before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$46.50M	USD	Annual
Income before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$101.40M	USD	Annual
Income before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$106.70M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$11.80M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-300.60M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$9.50M	USD	Annual
Net income	`NetIncomeLoss`	$37.00M	USD	Annual
Net income	`NetIncomeLoss`	$89.60M	USD	Annual
Net income	`NetIncomeLoss`	$407.30M	USD	Annual
Unrealized (loss) gain on debt securities available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.50M	USD	Annual
Unrealized (loss) gain on debt securities available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.40M	USD	Annual
Unrealized (loss) gain on debt securities available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$400.00K	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$86.10M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$40.40M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$407.70M	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.95	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$0.40	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$4.38	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$4.16	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.92	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$0.39	USD	Annual
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	91.60M	shares	Annual
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	94.60M	shares	Annual
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.10M	shares	Annual
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.90M	shares	Annual
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.80M	shares	Annual
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.70M	shares	Annual

Cash Flow Statement 89 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$37.00M	USD	Annual
Net income	`NetIncomeLoss`	$89.60M	USD	Annual
Net income	`NetIncomeLoss`	$407.30M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$100.00M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$134.20M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$75.30M	USD	Annual
Depreciation	`Depreciation`	$7.40M	USD	Annual
Depreciation	`Depreciation`	$8.60M	USD	Annual
Depreciation	`Depreciation`	$10.90M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$18.90M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$20.00M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$16.20M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.40M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.40M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.10M	USD	Annual
Change in fair value of equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-17.70M	USD	Annual
Change in fair value of equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$20.90M	USD	Annual
Change in fair value of equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-13.00M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	-	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$4.30M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-310.70M	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of convertible senior notes	`GainsLossesOnExtinguishmentOfDebt`	$-18.40M	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$4.40M	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$3.70M	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$-1.20M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$69.20M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$28.40M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$30.50M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$10.70M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$2.50M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$6.40M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$26.90M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$54.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$56.80M	USD	Annual
Other assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$-16.80M	USD	Annual
Other assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$9.20M	USD	Annual
Other assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$23.60M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$147.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$256.50M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$228.50M	USD	Annual
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$735.50M	USD	Annual
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$800.10M	USD	Annual
Purchases of debt securities available-for-sale	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$797.20M	USD	Annual
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$750.50M	USD	Annual
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$697.90M	USD	Annual
Sales and maturities of debt securities available-for-sale	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$669.70M	USD	Annual
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	$68.90M	USD	Annual
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	-	USD	Annual
Purchases of equity securities	`PaymentsToAcquireRestrictedInvestments`	$4.60M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.70M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.90M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.40M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-211.10M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-130.20M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.10M	USD	Annual
Issuances of common stock under benefit plans	`ProceedsFromIssuanceOfCommonStock`	$27.50M	USD	Annual
Issuances of common stock under benefit plans	`ProceedsFromIssuanceOfCommonStock`	$32.40M	USD	Annual
Issuances of common stock under benefit plans	`ProceedsFromIssuanceOfCommonStock`	$29.10M	USD	Annual
Partial repurchase of convertible senior notes	`RepaymentsOfConvertibleDebt`	$186.90M	USD	Annual
Partial repurchase of convertible senior notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Partial repurchase of convertible senior notes	`RepaymentsOfConvertibleDebt`	$100.00K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$32.40M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-157.80M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.40M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$153.70M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-31.70M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$74.80M	USD	Annual
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$190.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$344.00M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.50M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$190.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.20M	USD	Point-in-time
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.90M	USD	Annual
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.40M	USD	Annual
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.00M	USD	Annual
Right-of-use assets acquired through operating leases	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$12.80M	USD	Annual
Right-of-use assets acquired through operating leases	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$23.40M	USD	Annual
Right-of-use assets acquired through operating leases	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$77.10M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$8.60M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$11.60M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$11.60M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$15.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$500.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$5.10M	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$636.90M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.13B	USD	Point-in-time
Net income	`NetIncomeLoss`	$37.00M	USD	Annual
Net income	`NetIncomeLoss`	$89.60M	USD	Annual
Net income	`NetIncomeLoss`	$407.30M	USD	Annual
Unrealized gain (loss) on debt securities available-for sale	`MarketableSecuritiesUnrealizedGainLoss`	$400.00K	USD	Annual
Unrealized gain (loss) on debt securities available-for sale	`MarketableSecuritiesUnrealizedGainLoss`	$-3.50M	USD	Annual
Unrealized gain (loss) on debt securities available-for sale	`MarketableSecuritiesUnrealizedGainLoss`	$3.40M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$75.30M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$134.20M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$100.00M	USD	Annual
Issuances of common stock under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$27.50M	USD	Annual
Issuances of common stock under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$29.10M	USD	Annual
Issuances of common stock under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$32.40M	USD	Annual
Equity component of repurchased convertible senior notes, net	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments`	$47.50M	USD	Annual
Ending balance	`StockholdersEquity`	$636.90M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.37B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$480.80M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.13B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.